Literature DB >> 7371687

Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer.

J C Allegra, M E Lippman, E B Thompson, R Simon, A Barlock, L Green, K K Huff, H M Do, S C Aitken, R Warren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7371687     DOI： 10.1016/0014-2964(80)90348-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  19 in total

Review 1.  Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.

Authors:  David K Lung; Rebecca M Reese; Elaine T Alarid
Journal:  Horm Cancer       Date:  2020-06-26       Impact factor: 3.869

Review 2.  Targeted functional imaging in breast cancer.

Authors:  Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03       Impact factor: 9.236

3.  Luminal breast cancer metastasis is dependent on estrogen signaling.

Authors:  Vidya Ganapathy; Whitney Banach-Petrosky; Wen Xie; Aparna Kareddula; Hilde Nienhuis; Gregory Miles; Michael Reiss
Journal:  Clin Exp Metastasis       Date:  2012-03-17       Impact factor: 5.150

Review 4.  Systemic therapy in breast cancer: efficacy and cost utility.

Authors:  J F Corry; P E Lønning
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

5.  Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis.

Authors:  H M Scheres; A F De Goeij; M J Rousch; G G Hondius; D D Willebrand; A H Gijzen; F T Bosman
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

6.  Hormone receptors and human breast cancer.

Authors: 
Journal:  Br Med J       Date:  1980-09-13

Review 7.  Review of general surgery 1980.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1981-06       Impact factor: 2.401

8.  A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer.

Authors:  J C Allegra; T M Woodcock; S P Richman; K I Bland; J L Wittliff
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

9.  Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues.

Authors:  R R Mehta; T K DasGupta
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

10.  Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.

Authors:  J E Macheledt; A U Buzdar; G N Hortobagyi; D K Frye; J U Gutterman; F A Holmes
Journal:  Breast Cancer Res Treat       Date:  1991-08       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.